Buchumschlag

Paediatric‐onset immune‐mediated inflammatory disease is associated with an increased mortality risk—A nationwide study

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Mikkel Malham, Sabine Jansson, Helene Ingels, Marianne Hørby Jørgensen, Naja Hulvej Rod, Vibeke Wewer, Matthew P. Fox
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood—Authors' reply
von: Mikkel Malham, et al.
Veröffentlicht: (2024)

Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018
von: Rie Louise Møller Nordestgaard, et al.
Veröffentlicht: (2024)

Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood
von: Paul Henderson
Veröffentlicht: (2024)

Allostatic load increases the incidence and risk of adverse prognosis in inflammatory bowel disease
von: Jianhui Zhao, et al.
Veröffentlicht: (2024)

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium
von: Amanda Ricciuto, et al.
Veröffentlicht: (2024)

Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
von: Yewan Park, et al.
Veröffentlicht: (2024)

Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply
von: Vibeke Strande, et al.
Veröffentlicht: (2024)

Editorial: Upadacitinib—A Promising Induction Agent for Paediatric Crohn's Disease?
von: Vincenzo Stranges, et al.
Veröffentlicht: (2025)

Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study
von: Shlomi Cohen, et al.
Veröffentlicht: (2025)

The use of opioids nine months after surgery for Crohn's disease – a nationwide cohort study
von: Bente Mertz Nørgård, et al.
Veröffentlicht: (2024)

Letter: Peripheral Eosinophilia Does Not Correlate With Endoscopic and Histological Activity in Paediatric Eosinophilic Oesophagitis
von: Saverio Pochesci, et al.
Veröffentlicht: (2026)

Letter: Differences in Disease Characteristics and Treatment Exposures Between Paediatric and Adult‐Onset IBD
von: Xinli Chen, et al.
Veröffentlicht: (2024)

Review article: Prevention of inflammatory bowel disease—The path forward
von: Sérgio Bronze, et al.
Veröffentlicht: (2024)

Letter: Peripheral Eosinophilia Does Not Correlate With Endoscopic and Histological Activity in Paediatric Eosinophilic Oesophagitis. Authors' Reply
von: Pierfrancesco Visaggi, et al.
Veröffentlicht: (2026)

Letter: Enhancing Predictive Models for Paediatric Ulcerative Colitis—Addressing Socioeconomic, Environmental and Clinical Factors. Authors' Reply
von: Merle Claßen, et al.
Veröffentlicht: (2024)

Editorial: GLP‐1 receptor agonists in inflammatory bowel disease—Is it time?
von: Konstantinos Arvanitakis, et al.
Veröffentlicht: (2024)

Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
von: Nurulamin M. Noor, et al.
Veröffentlicht: (2024)

Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
von: Tsz Hong Yiu, et al.
Veröffentlicht: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
von: Peter R. Gibson, et al.
Veröffentlicht: (2024)

Editorial: Treatments for inflammatory bowel disease across the age‐spectrum—Are they the same?
von: Agnes Hiu Yan Ho, et al.
Veröffentlicht: (2024)

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply
von: Abhinav Vasudevan, et al.
Veröffentlicht: (2024)

Letter: Allostatic load—A potential key in the development of inflammatory bowel disease
von: Maryam Kharal, et al.
Veröffentlicht: (2024)

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply
von: Abhinav Vasudevan, et al.
Veröffentlicht: (2024)

Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
von: Thanaboon Chaemsupaphan, et al.
Veröffentlicht: (2024)

Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease
von: Léa Sequier, et al.
Veröffentlicht: (2024)

Myokines are associated with progression, course and mortality in alcohol‐associated liver disease
von: Parminder Kaur, et al.
Veröffentlicht: (2024)

Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis
von: Marcus M. Mücke, et al.
Veröffentlicht: (2024)

Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission
von: Arta Aliu, et al.
Veröffentlicht: (2024)

Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease
von: R. M. Mathias, et al.
Veröffentlicht: (2024)

Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
von: Christy Riggott, et al.
Veröffentlicht: (2024)

Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies
von: Iris Barth, et al.
Veröffentlicht: (2024)

Letter: Microbial manipulation for primary sclerosing cholangitis‐associated inflammatory bowel disease—hope on the horizon
von: D. Bogatic, et al.
Veröffentlicht: (2024)

Editorial: Distinct Challenges of Paediatric From Adult‐Onset Inflammatory Bowel Disease, Implications of Aggressive Disease Phenotypes and Early Biologic Therapy in Children
von: Alessandro Molinaro, et al.
Veröffentlicht: (2024)

Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms–still a long way to go…
von: Sabine Roman, et al.
Veröffentlicht: (2024)

Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study
von: Carl Eriksson, et al.
Veröffentlicht: (2024)

Meta‐analysis: High pooled positive predictive value of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition no‐biopsy approach for coeliac disease testing in children
von: Angharad Vernon‐Roberts, et al.
Veröffentlicht: (2024)

Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United States
von: Donghee Kim, et al.
Veröffentlicht: (2024)

Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?
von: Ayesha Shah, et al.
Veröffentlicht: (2024)

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors
von: Matthew J. Townsend, et al.
Veröffentlicht: (2024)

Dietary factors and patterns in relation to risk of later‐onset ulcerative colitis in Chinese: A prospective study of 0.5 million people
von: Shuyao Song, et al.
Veröffentlicht: (2024)